Seeking Alpha

SA Editor Colin Lokey

View as an RSS Feed
View SA Editor Colin Lokey's Comments BY TICKER:
Latest  |  Highest rated
  • Trish Regan, Einhorn Apologist [View article]
    David Siegel did a fantastic job on Bloomberg TV.
    Mar 25 12:04 AM | Likes Like |Link to Comment
  • Nicholas Financial: A Bad Deal - Vote It Down, Replace Directors, And Profit [View article]
    Although we welcome and encourage constructive debate, we should all remember that what makes Seeking Alpha such a wonderful platform is that everyone is encouraged to share their opinions. No one wins if contributors are discouraged from discussing their ideas.

    If you believe there is misinformation, we encourage you to write an article and share your insights with the SA community.
    Mar 3 04:11 PM | 4 Likes Like |Link to Comment
  • Finding Alpha In Event-Driven Patent-Litigation Investments [View article]
    I think very few investors have any kind of visibility into this space. One of the great things about this article, for me anyway, was that it better prepared me to read and understand their other articles.
    Feb 20 02:45 PM | 2 Likes Like |Link to Comment
  • Finding Alpha In Event-Driven Patent-Litigation Investments [View article]
    Please refer to Markman Advisors' articles here on Seeking Alpha for more in-depth analysis.
    Feb 20 12:19 PM | 1 Like Like |Link to Comment
  • SA Tech Experts: Comment On CNBC's "Leaders, Icons, & Rebels" List [View instapost]
    Interesting perspectives there. Anyone else?
    Feb 1 09:49 AM | Likes Like |Link to Comment
  • Contributors For New York Television Appearances [View instapost]
    Stay tuned Alexander!
    Jan 31 07:01 PM | Likes Like |Link to Comment
  • Radio Spots Available [View instapost]
    Great. I'll be in touch
    Jan 29 01:30 PM | Likes Like |Link to Comment
  • Beam - An Attractive Investment Opportunity [View article]
    Yes, excellent call indeed.
    Jan 14 05:27 PM | 1 Like Like |Link to Comment
  • Cell Therapeutics outlines integrated Phase 2 pacritinib data at ASH [View news story]
    This Market Current merely reports the price move and the data released by the company — it is entirely objective. Aside from the price action, the bullet points carry no negative connotation.
    Dec 9 04:08 PM | Likes Like |Link to Comment
  • Synta Pharmaceuticals announces offering, shares fall [View news story]
    See here: http://seekingalpha.co...
    Nov 13 09:08 AM | Likes Like |Link to Comment
  • Synta Pharmaceuticals announces offering, shares fall [View news story]
    Please note that the requested information wasn't in the PR.
    Nov 13 09:04 AM | Likes Like |Link to Comment
  • Weekly IMS data for key weight-loss drugs [View news story]
    Corrected.
    Oct 4 01:53 PM | Likes Like |Link to Comment
  • Lockhart expresses concern about jobs, Fisher says Fed's credibility damaged [View news story]
    Putting the recovery at "five years old" would mean it started the week Lehman collapsed.
    Sep 23 02:33 PM | Likes Like |Link to Comment
  • Unilife soars on new Sanofi deal [View news story]
    The "replaces and supersedes" is directly from the company's PR.
    Sep 11 03:55 PM | Likes Like |Link to Comment
  • Herbalife hits new 52-week high, Monday saw big options trade [View news story]
    Also, the calculus would change a bit if you happened to own the underlying shares and you bought them way lower than the strike on the short leg...
    Sep 10 11:32 AM | Likes Like |Link to Comment
COMMENTS STATS
443 Comments
547 Likes